Barr Pharmaceuticals, Inc. (BRL)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
225 SUMMIT AVE MONTVALE, NJ 07645-1523

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Barr Pharmaceuticals is a specialty pharmaceutical company. Co. develops, manufactures and markets generic and proprietary pharmaceutical products. Co.'s generic product portfolio includes solid oral dosage forms, injectables and cream/ointment products. At Dec 31 2007, Co. marketed for sale in the U.S., about 245 different dosage forms and strengths of about 120 different generic pharmaceutical products, including 25 oral contraceptive products; and in Europe and the rest of the world, approximately 1,025 generic pharmaceutical products. Co.'s products include SEASONIQUE, PLAN BNULL and PARAGARD T 380A.

View SEC Filings from BRL instead.

View recent insider trading info

Barr Pharmaceuticals, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BRL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BRL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CHEFITZ HAROLD N INSIDER

  • Officer
 No longer subject to file 2008-12-23 0

BOGDA MICHAEL PRESIDENT & COO

  • Officer
 No longer subject to file 2008-12-23 0

DOWNEY BRUCE CHAIRMAN & CEO

  • Officer
  • Director
 No longer subject to file 2008-12-23 0

KILLION FREDERICK GENERAL COUNSEL

  • Officer
 No longer subject to file 2008-12-23 0

MCKEE WILLIAM EVP, CFO

  • Officer
 No longer subject to file 2008-12-23 0

MUNDKUR CHRISTINE CHIEF EXECUTIVE OFFICER

  • Officer
 No longer subject to file 2008-12-23 0

FRANKOVIC RICHARD

  • Director
 No longer subject to file 2008-12-23 0

SEAVER PETER INSIDER

  • Officer
 No longer subject to file 2008-12-23 0

STEPHAN GEORGE INSIDER

  • Officer
 No longer subject to file 2008-12-23 0

WILKINSON GEORGE FRED PRESIDENT & COO

  • Officer
 No longer subject to file 2008-12-23 0

SAWYER TIMOTHY EXECUTIVE VP

  • Officer
 No longer subject to file 2008-12-23 0

COVIC ZELJKO COO OF PLIVA D.D.

  • Officer
 No longer subject to file 2008-12-23 0

GREENMAN JANE F EXECUTIVE VP, GLOBAL HR

  • Officer
 No longer subject to file 2008-12-23 0

KIRK SIGURD SR VP FINANCE & CORP CONTROLLE

  • Officer
 No longer subject to file 2008-12-23 0

GILMORE JAMES III INSIDER

  • Officer
 0 2008-12-16 0

GIOIA PHILIP SR VP,GENERIC SALES & MARKETIN

  • Officer
 0 2008-03-04 0

BISARO PAUL

  • FORMER PRESIDENT & COO
 282,475 2007-10-22 0

HIGGINS CATHERINE SR.VP, HUMAN RESOURCES

  • Officer
 48,190 2007-06-28 0

MENGLER CHRISTOPHER SR. VP

  • Officer
 15,000 2007-03-07 0

BEN MAIMON CAROL PRESIDENT & COO BARR RES

  • Officer
  • Director
 14,377 2006-08-24 0

AMED SALAH SR.VP, R&D

  • Officer
 30,000 2006-07-26 0

CATLETT TIMOTHY SR.VP, SALES & MARKETING

  • Officer
 30,000 2006-07-26 0

DONAGHY SUZANNE SR VICE PRESIDENT/CIO

  • Officer
 38,180 2006-03-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments